Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions
- PMID: 22105816
- PMCID: PMC3387488
- DOI: 10.1001/archdermatol.2011.338
Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions
Abstract
Objective: To investigate the usefulness of a novel marker for melanocytic proliferations.
Design: Using a novel monoclonal antibody against soluble adenylyl cyclase (sAC), various benign and malignant melanocytic proliferations were immunostained.
Setting: Weill Medical College of Cornell University dermatopathology laboratory.
Main outcome measures: The results were qualitative, not quantifiable.
Results: The sAC immunostaining produced distinctive patterns that paralleled melanomagenesis. At one pole of the spectrum were benign nevi, including atypical nevi of special sites and recurrent nevi showing a distinct pattern of dotlike Golgi staining, while at the opposite pole was melanoma, in which many cells demonstrated an intense pannuclear expression pattern, often accompanied by loss of the Golgi expression pattern. Melanomas of lentigo maligna and acral lentiginous subtypes exhibited the most striking pannuclear expression, while nodular melanomas showed the least, although with supervening enhanced diffuse cytoplasmic expression. Loss of the Golgi expression pattern was a feature of malignant melanoma.
Conclusion: The sAC expression pattern is complex but seems discriminatory, with distinctive and variable staining patterns according to the nature of the lesion biopsied.
Figures







Similar articles
-
Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.Arch Pathol Lab Med. 2012 Dec;136(12):1558-64. doi: 10.5858/arpa.2011-0617-OA. Arch Pathol Lab Med. 2012. PMID: 23194049 Free PMC article.
-
PRAME Expression in Melanocytic Tumors.Am J Surg Pathol. 2018 Nov;42(11):1456-1465. doi: 10.1097/PAS.0000000000001134. Am J Surg Pathol. 2018. PMID: 30045064 Free PMC article.
-
Black lesions of the skin.Calif Med. 1958 Mar;88(3):228-33. Calif Med. 1958. PMID: 13511215 Free PMC article.
-
Lentiginous melanoma.Arch Pathol Lab Med. 2011 Mar;135(3):337-41. doi: 10.5858/2009-0538-RA.1. Arch Pathol Lab Med. 2011. PMID: 21366457 Review.
-
Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.Clin Plast Surg. 2000 Jul;27(3):331-60, viii. Clin Plast Surg. 2000. PMID: 10941557 Review.
Cited by
-
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.Cancers (Basel). 2022 Jan 29;14(3):706. doi: 10.3390/cancers14030706. Cancers (Basel). 2022. PMID: 35158973 Free PMC article. Review.
-
Mammalian pigmentation is regulated by a distinct cAMP-dependent mechanism that controls melanosome pH.Sci Signal. 2018 Nov 6;11(555):eaau7987. doi: 10.1126/scisignal.aau7987. Sci Signal. 2018. PMID: 30401788 Free PMC article.
-
Established and potential physiological roles of bicarbonate-sensing soluble adenylyl cyclase (sAC) in aquatic animals.J Exp Biol. 2014 Mar 1;217(Pt 5):663-72. doi: 10.1242/jeb.086157. J Exp Biol. 2014. PMID: 24574382 Free PMC article. Review.
-
Diagnostic and prognostic biomarkers in melanoma.J Clin Aesthet Dermatol. 2014 Jun;7(6):13-24. J Clin Aesthet Dermatol. 2014. PMID: 25013535 Free PMC article. Review.
-
Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells.J Biol Chem. 2013 Feb 1;288(5):3126-35. doi: 10.1074/jbc.M112.403279. Epub 2012 Dec 19. J Biol Chem. 2013. PMID: 23255611 Free PMC article.
References
-
- Crowson AN, Magro CM, Mihm MC. The Melanocytic Proliferations: a Comprehensive Textbook of Pigmented Lesions. New York, NY: Wiley-Liss; 2001.
-
- Lebe B, Pabuççuoğlu U, Ozer E. The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions. Appl Immunohistochem Mol Morphol. 2007;15(2):160–164. - PubMed
-
- Li LX, Crotty KA, McCarthy SW, Palmer AA, Kril JJ. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol. 2000;22(6):489–495. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical